Disclosure of Certain Asthmatx Future IP. Subject to the confidentiality provisions of Section 11 of this Agreement, Asthmatx will disclose in confidence to Broncus any Asthmatx Future IP that is described in Section 1.7(b)(ii) that may be developed by Asthmatx. Such disclosure will be made within a reasonable time after such Asthmatx Future IP has been developed and reduced to practice.
Appears in 5 contracts
Samples: Cross License Agreement (Broncus Technologies Inc/Ca), Cross License Agreement (Asthmatx Inc), Cross License Agreement (Asthmatx Inc)